This fifth episode of the EASL Policy Dialogues Episodes gave the floor to patient advocates to discuss the stigmatisation surrounding liver diseases.
How and why does stigma affect people with liver disease? What are the consequences for people with liver disease facing stigma? Which actions should be prioritised to mitigate the impact of stigma?
Listen to ELPA President Marko Korenjak commenting on this important topic with Rachel Halford, CEO at The Hepatitis C Trust and part of the Board of Directors of Liver Patients International.